Elizabeth Ofili is a Cardiology physician affiliated with Morehouse School of Medicine. OpenAlex indexes 173 publications with 13,557 citations (h-index 44).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1800 Howell Mill Rd NW Ste 275
Atlanta, GA 303183098
Telephone
404-756-1290Provider last certified this registry record 10 Jul 2021.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Amgen Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Statin28.3%Atorvastatin Calcium100%Part D≥11 patientsBeta blocker27.2%Metoprolol Succinate100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
21 NIH research awards on record, funded 1994–2026 per NIH RePORTER. The latest:
- Georgia Clinical & Translational Science Alliance (Georgia CTSA)
Emory University
FY2026$9,325,448UL1TR002378 - Research Centers in Minority Institutions (RCMI) Coordinating Center
Morehouse School of Medicine
FY2026$2,926,618U24MD015970 - Health360x.ai: Accelerating Access to Medical Breakthroughs at the Point of Care
Accuhealth Technologies, Inc.
FY2026$311,977R44MD021394
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
New England Journal of Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Jalal Ghali, MD
Morehouse School of Medicine
Madeline Sutton, MD
Morehouse School of Medicine
Arash Heidari, MD
Morehouse School of Medicine
Anekwe Onwuanyi, MD
Morehouse School of Medicine
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”